Dr. Vinay Prasad is back at the FDA's Center for Biologics Evaluation and Research, raising eyebrows after being ousted amid political turmoil and criticism. His return ignites debates about drug approvals and public health leadership under the Trump administration.
Texas GOP leaders are urging the FBI to assist in locating over 50 Democratic lawmakers who fled the state to avoid a contentious vote on redistricting, raising questions about federal involvement in state politics.
In a surprising turn of events, President Trump has dismissed IRS Commissioner Billy Long just two months after his Senate confirmation. This decision raises questions amid controversies surrounding Long's past work and allegations of fraud.
In a recent press conference, Trump discusses his fallout with Epstein and the possibility of a Maxwell pardon, claiming the allegations against him are a political hoax. Discover the latest updates here!
President Trump heads to Scotland for a controversial golf trip, blending business with presidential duties. Critics raise concerns over ethical implications and foreign entanglements.
In a surprising move, Republicans end their House session early amid mounting pressure to vote on the release of Jeffrey Epstein's files. Democrats claim it's a sign of fear over accountability. What’s behind the rush?
In a surprising move, House Republicans have proposed renaming the Kennedy Center's opera house after Melania Trump, sparking a fierce political debate. Democrats accuse the GOP of sneaking in this controversial plan amidst ongoing discussions.
Tennessee Rep. Tim Burchett is leading the charge for the release of Jeffrey Epstein's files, pushing back against Trump's dismissal of the efforts as foolish. As calls for transparency grow, can the truth about Epstein finally come to light?
In a contentious Senate Judiciary Committee hearing, President Trump's judicial nominee Emil Bove advanced despite Democratic objections and a walkout. Bove faces serious whistleblower allegations that could derail his confirmation.
In a stunning move, over 900 former DOJ employees have rallied against Emil Bove's nomination to the Third Circuit U.S. Court of Appeals, citing grave concerns over his leadership and controversial actions during the Trump era.
